<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20</volume><submitter>Xu Q</submitter><pubmed_abstract>Filamin B (FLNB) plays an important role in skeletal development. Mutations in &lt;i>FLNB&lt;/i> can lead to skeletal malformation such as an abnormal number of ossification centers, indicating that the skeletal segmentation in the embryonic period may be interfered with. We established a mouse model with the pathogenic point mutation &lt;i>FLNB&lt;/i> NM_001081427.1: c.4756G > A (p.Gly1586Arg) using CRISPR-Cas9 technology. Micro-CT, HE staining and whole skeletal preparation were performed to examine the skeletal malformation. &lt;i>In situ&lt;/i> hybridization of embryos was performed to examine the transcription of &lt;i>HOX&lt;/i> genes during embryonic development. The expression of &lt;i>FLNB&lt;/i> was downregulated in &lt;i>FLNB&lt;/i>&lt;sup>&lt;i>G1586R/G1586R&lt;/i>&lt;/sup> and &lt;i>FLNB&lt;/i>&lt;sup>&lt;i>WT/G1586R&lt;/i>&lt;/sup> mice, co</pubmed_abstract><journal>Bone reports</journal><pagination>101746</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10924170</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Disruption of &lt;i>FLNB&lt;/i> leads to skeletal malformation by interfering with skeletal segmentation through the &lt;i>HOX&lt;/i> gene.</pubmed_title><pmcid>PMC10924170</pmcid><pubmed_authors>Cui L</pubmed_authors><pubmed_authors>Xu Q</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Cui LA</pubmed_authors><pubmed_authors>Xia W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disruption of &lt;i>FLNB&lt;/i> leads to skeletal malformation by interfering with skeletal segmentation through the &lt;i>HOX&lt;/i> gene.</name><description>Filamin B (FLNB) plays an important role in skeletal development. Mutations in &lt;i>FLNB&lt;/i> can lead to skeletal malformation such as an abnormal number of ossification centers, indicating that the skeletal segmentation in the embryonic period may be interfered with. We established a mouse model with the pathogenic point mutation &lt;i>FLNB&lt;/i> NM_001081427.1: c.4756G > A (p.Gly1586Arg) using CRISPR-Cas9 technology. Micro-CT, HE staining and whole skeletal preparation were performed to examine the skeletal malformation. &lt;i>In situ&lt;/i> hybridization of embryos was performed to examine the transcription of &lt;i>HOX&lt;/i> genes during embryonic development. The expression of &lt;i>FLNB&lt;/i> was downregulated in &lt;i>FLNB&lt;/i>&lt;sup>&lt;i>G1586R/G1586R&lt;/i>&lt;/sup> and &lt;i>FLNB&lt;/i>&lt;sup>&lt;i>WT/G1586R&lt;/i>&lt;/sup> mice, co</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T21:31:04.842Z</modification><creation>2025-04-04T21:31:04.842Z</creation></dates><accession>S-EPMC10924170</accession><cross_references><pubmed>38463381</pubmed><doi>10.1016/j.bonr.2024.101746</doi></cross_references></HashMap>